Question 1

Is Cosmos Health, Inc. overvalued or undervalued?

Accepted Answer

As of 18 May 2016, the valuation grade for Cosmos Health, Inc. moved from does not qualify to risky, indicating a deterioration in its financial standing. The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of 0.54, an EV to EBIT of -1.87, and an EV to EBITDA of -2.06. In comparison, TFF Pharmaceuticals, Inc. has a less negative EV to EBITDA of 0.1173, suggesting that Cosmos is struggling relative to its peers.The company's recent stock performance shows a 39.30% return year-to-date, significantly outperforming the S&P 500's 12.22% return in the same period. However, over longer horizons, such as the 3-year and 5-year returns of -89.93% and -98.82%, respectively, indicate severe underperformance compared to the S&P 500's gains. Overall, Cosmos Health, Inc. is deemed overvalued based on its financial metrics and peer comparisons.

Question 2

Is Cosmos Health, Inc. technically bullish or bearish?

Accepted Answer

As of 11 September 2025, the technical trend for Cosmos Health, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages are also bullish, indicating positive momentum. However, the weekly RSI is bearish, suggesting some short-term weakness. The Bollinger Bands show a mildly bullish stance on the weekly and bullish on the monthly, reinforcing the upward trend. The KST is bullish weekly and mildly bullish monthly, while the OBV is bullish monthly, indicating accumulation.In terms of performance, Cosmos Health has outperformed the S&P 500 over the past week and month, with returns of 10.95% and 9.88% respectively, compared to 1.05% and 2.33% for the index. However, the longer-term returns (1Y, 3Y, 5Y, and 10Y) are significantly negative compared to the S&P 500, indicating a challenging historical performance.Overall, the current technical stance is bullish, driven primarily by the positive signals from moving averages and MACD, despite some mixed signals from the RSI and longer-term performance.

Question 3

How big is Cosmos Health, Inc.?

Accepted Answer

As of Jun 18, Cosmos Health, Inc. has a market capitalization of 12.40 million, categorizing it as a Micro Cap company.As of Jun 18, the sum of net sales for the latest four quarters is 53.55 million, while the sum of net profit for the same period is -15.13 million.As of Dec 24, the shareholder's funds are reported at 24.53 million, and total assets amount to 54.31 million.

Question 4

What does Cosmos Health, Inc. do?

Accepted Answer

Overview:  Cosmos Health, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot:  Most recent Net Sales: 14 Million (Quarterly Results - Mar 2025)  Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025)  Market-cap: USD 12.40 Million (Micro Cap)Key Metrics:  P/E: NA (Loss Making)  Industry P/E: NA  Dividend Yield: 0.00%  Debt Equity: 0.45  Return on Equity: -57.21%  Price to Book: 0.48Contact Details:  Registrar Address: Not available.

Question 5

Should I buy, sell or hold Cosmos Health, Inc.?

Accepted Answer

Based on the current analysis of Cosmos Health, Inc., it would be advisable to consider selling your shares. The company is facing several challenges, including poor management efficiency reflected in a low Return on Capital Employed (ROCE) of 1.92%, indicating low profitability relative to its capital. Additionally, the long-term growth prospects appear weak, with net sales growing at an annual rate of only 6.18% over the past five years.Moreover, the recent financial results show concerning trends, such as a significant year-over-year increase in raw material costs by 34.69%, which could further pressure margins. The company is also operating with negative EBITDA, suggesting that it is not generating sufficient earnings before interest, taxes, depreciation, and amortization to cover its expenses. Given these factors, the stock's risk profile is elevated, and the lack of returns over the past year, despite a rise in profits, adds to the uncertainty.Overall, the combination of these financial indicators suggests that it may be prudent to sell your shares in Cosmos Health, Inc. at this time.

Cosmos Health, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

Is Cosmos Health, Inc. overvalued or undervalued?

Is Cosmos Health, Inc. technically bullish or bearish?

How big is Cosmos Health, Inc.?

What does Cosmos Health, Inc. do?

Should I buy, sell or hold Cosmos Health, Inc.?

Compare Cosmos Health, Inc. with Similar Stocks

Dashboard

High Debt company with Weak Long Term Fundamental Strength

Negative results in Mar 26

Risky -

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Annual Results Snapshot (Consolidated) - Dec'25

About Cosmos Health, Inc.

Company Coordinates